RBC Capital analyst Sean Dodge maintained a Buy rating on Healthequity (HQY – Research Report) on June 6 and set a price target of $70.00. The company's shares closed last Friday at $64.05. According to TipRanks.com, Dodge is a 1-star analyst with an average return of -2.1% and a 44.5% success rate. Dodge covers the Technology sector, focusing on stocks such as Tabula Rasa HealthCare, NextGen Healthcare, and Thorne HealthTech. Healthequity has an analyst consensus of Strong Buy, with a price target consensus of $77.82, which is a 25.3% upside from current levels.
https://www.tipranks.com/news/blurbs/healthequity-hqy-receives-a-buy-from-rbc-capital-2?utm_source=advfn.com&utm_medium=referral
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more HealthEquity Charts.
HealthEquity (NASDAQ:HQY)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more HealthEquity Charts.